Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis
Other
OA: closed
CC0
⤵ 23 in-corpus citations
AI-generated summary
This study investigated the impact of dienogest on pain and endometrioma recurrence following laparoscopic uterosacral ligament resection for deep infiltrating endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To evaluate the effect of dienogest (DNG) in preventing the occurrence of pain and endometriomas after laparoscopic resection of uterosacral ligaments (USLs) with deep infiltrating endometriosis (DIE).
STUDY DESIGN: This retrospective analysis included 126 patients who underwent laparoscopic resection of USLs with DIE followed by postoperative administration of DNG or no medication. Every 6 months postoperatively, patients answered questions and underwent ultrasound examination to identify pain and/or endometrioma.
RESULT: There were three (5.0%) cases of endometrioma in 59 patients from the DNG group and 21 (31.3%) cases in 67 patients from the no medication group (P=0.0002). Pain returned to preoperative levels in eight (11.9%) cases in the no medication group. No recurrence of pain occurred in the DNG group (P=0.0061).
CONCLUSION: The administration of DNG after resection of USLs with DIE significantly reduces the occurrence rate of endometriosis-related pain and endometriomas.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (25)
- A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis via openalex
- Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification via openalex
- Association rate between deep peritoneal endometriosis and other forms of the disease: pathogenetic implications via openalex
- Comparison of complete and incomplete excision of deep infiltrating endometriosis via openalex
- Comparison of Complete and Incomplete Excision of Deep Infiltrating Endometriosis via openalex
- Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis via openalex
- Dienogest: a new therapeutic agent for the treatment of endometriosis via openalex
- Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture via openalex
- Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
- Endometriosis: what is the risk of hospital admission, readmission, and major surgical intervention? via openalex
- Long-Term Administration of Dienogest Reduces Recurrence after Excision of Endometrioma via openalex
- Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex
- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy via openalex
- Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial via openalex
- Medical treatment for rectovaginal endometriosis: what is the evidence? via openalex
- Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis via openalex
- Surgery versus hormonal therapy for deep endometriosis: is it a choice of the physician? via openalex
- W6714496033 via openalex
- W2024158781 via openalex
- W2079421112 via openalex
- W2100503022 via openalex
- W2126339803 via openalex
- W2130203785 via openalex
- W2163315477 via openalex
- W1516382093 via openalex
Cited by (24)
- Reproductive outcomes after expectant management and 5- versus 15-minute laparoscopic ethanol sclerotherapy for ovarian endometriomas: a retrospective cohort study 2026
- Efficacy and safety of dienogest in the treatment of deep infiltrating endometriosis: A meta-analysis 2024
- Dienogest therapy: a window of opportunity for endometriosis 2023
- The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery: a Systematic Review and Meta-Analysis 2023
- Evaluation of long-term efficacy and safety of dienogest in patients with chronic cyclic pelvic pain associated with endometriosis 2023
- Progesterone receptor ligands for the treatment of endometriosis 2022
- Cost-effectiveness Analysis of Dienogest Compared with Combined Oral Contraceptives after Surgery for Endometriosis 2022
- Application of Dienogest In the Treatment of Endometriosis 2022
- Efficacy of Dienogest for Prevention of Endometriosis Recurrence: A Systematic Review and Meta-Analysis 2022
- Endometriosis, hormonal therapy and oncological risks 2021
- Patient-reported utilization patterns of endometriosis medications in Europe: Real-world results from the non-interventional VIPOS study 2021
- Dienogest as a Maintenance Treatment for Endometriosis Following Surgery: A Systematic Review and Meta-Analysis 2021
- Clinical and diagnostic aspects of deep infiltrative endometriosis (diagnosis, treatment, recurrence) 2021
- Gestagenes in the treatment of endometriosis: efficiency, safety, bioequivalence, transferability 2021
- Hormonresistenz in der medikamentösen Therapie der Endometriose 2020
- Use of dienogest in endometriosis: a narrative literature review and expert commentary 2020
- Dienogest and the Risk of Endometriosis Recurrence Following Surgery: A Systematic Review and Meta-analysis 2020
- Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery 2019
- Is Long-Term Dienogest Treatment Tolerable in Korea? 2019
- Clinical studies investigating the use of leuprorelin in Asian women with endometriosis: a review 2019
- Reviewing the role of progesterone therapy in endometriosis 2018
- Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis 2018
- Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice 2018
- Dienogest in the Treatment of Endometriosis 2017
Source provenance
- europepmc
- last seen: 2026-10-25T09:32:14.900964+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:20:19.361389+00:00
- unpaywall
- last seen: 2026-10-25T06:24:14.523685+00:00
License: CC0
· commercial use OK